Inter-day reliability of heart rate complexity and variability metrics in healthy highly active younger and older adults.

PURPOSE: To investigate the inter-day reliability of time-domain, frequency-domain, and nonlinear HRV metrics in healthy highly active younger and older adults. The study also assessed the effect of age on the HRV metrics. METHODS: Forty-four older adults (34 M, 10F; 59 ± 5 years; [Formula: see text] = 40.9 ± 7.6 ml kg-1 min-1) and twenty-two younger adults (16 M, 6F; 22 ± 4 years; [Formula: see text] = 47.2 ± 12.8 ml kg-1 min-1) attended the laboratory. Visit one assessed aerobic fitness through an exercise test. In visits two and three, participants completed a 30-min supine RR interval measurement to derive the HRV metrics. RESULTS: The younger group (YG) and older group (OG) demonstrated poor to good day-to-day relative and absolute reliability for all HRV metrics (OG, ICCs = 0.33 to 0.69 and between day CVs = 3.8 to 29.2%; YG, ICCs = 0.37 to 0.93 and between day CVs = 3.5 to 36.5%). There was a significant reduction in ApEn (P < 0.001), SampEn (P = 0.031), RMSSD (P < 0.001), SDNN (P < 0.001), LF power (P < 0.001) and HF power (P < 0.001), HRV metrics with ageing. There was no significant effect of age the complexity metrics DFA α1 (P = 0.107), α2 (P = 0.147) and CI-8 (P = 0.493). CONCLUSION: HRV metrics are reproducible between days in both healthy highly active younger and older adults. There is a decline in linear and nonlinear HRV metrics with age, albeit there being no age-related change in the nonlinear metrics, DFA α1, α2 and CI-8.

Tramadol is a performance-enhancing drug in highly trained cyclists: a randomized controlled trial.

Tramadol is a potent narcotic analgesic reportedly used in multiple sports to reduce exertional pain and confer a performance advantage. This study sought to identify whether tramadol enhances performance in time trial cycling. Twenty-seven highly trained cyclists were screened for tramadol sensitivity and then attended the laboratory across three visits. Visit 1 identified maximal oxygen uptake, peak power output, and gas exchange threshold through a ramp incremental test. Participants returned to the laboratory on two further occasions to undertake cycling performance tests following the ingestion of either 100 mg of soluble tramadol or a taste-matched placebo control in a double-blind, randomized, and crossover design. In the performance tests, participants completed a 30 min non-exhaustive fixed intensity cycling task at a heavy exercise intensity (272 ± 42 W), immediately followed by a competitive self-paced 25-mile time trial (TT). Following removal of two outlier data sets, analysis was completed on n = 25. Participants completed the TT significantly faster (d = 0.54, P = 0.012) in the tramadol condition (3758 s ± 232 s) compared with the placebo condition (3808 s ± 248 s) and maintained a significantly higher mean power output (+9 W) throughout the TT (ηp2 = 0.262, P = 0.009). Tramadol reduced perception of effort during the fixed intensity trial (P = 0.026). The 1.3% faster time in the tramadol condition would be sufficient to change the outcomes of a race and is highly meaningful and pervasive in this cohort of highly trained cyclists. The data from this study suggests that tramadol is a performance-enhancing drug.NEW & NOTEWORTHY In the current study, when cycling with tramadol participants completed a time trial on average 50 s faster and at a 9 W higher power output than the placebo control. The study used both a fixed intensity and self-paced time trial exercise tasks to reflect the demands of a stage race. The outcomes from this study were used by the World Anti-Doping Agency to inform their addition of tramadol to the Prohibited List in 2024.

Reproducibility of NIRS-derived mitochondrial oxidative capacity in highly active older adults.

INTRODUCTION: In-vivo techniques using near-infrared spectroscopy (NIRS) have been developed to assess skeletal muscle mitochondrial oxidative capacity. However, the test-retest and day-to-day reliability of NIRS-derived mitochondrial oxidative capacity has yet to be established in older individuals. Therefore, the primary aim of this study was to determine the day-to-day and test-retest reliability of NIRS-derived mitochondrial oxidative capacity in older adults. The secondary aim was to examine the relationship between NIRS-derived mitochondrial capacity and whole-body aerobic fitness. MATERIAL AND METHODS: Twenty-four healthy individuals (19 M, 5F; aged 60 ± 4 years; maximal oxygen uptake (V̇O2peak) = 41.2 ± 6.8 ml.kg-1.min-1) completed three visits to the laboratory. Visit one assessed isometric maximal voluntary contractions of the knee extensors and aerobic capacity through an incremental exercise test. In visits two and three participants completed two measurements of NIRS-derived mitochondrial oxidative capacity in the vastus lateralis (VL). RESULTS: NIRS-derived mitochondrial oxidative capacity was found to have good to excellent day-to-day reliability (Day 1 vs Day 2; coefficient of variation (CV) = 7.0 %; standard error of measurement (SEM) = 5.2; intra-class correlation coefficient (ICC) = 0.94) and test re-test reliability (Day 1 [Test 1 vs Test 2]; CV = 5.0 %; SEM = 3.7; ICC 0.97 and Day 2 [Test 1 vs Test 2]; CV = 6.3 %; SEM = 4.9; ICC = 0.93). NIRS-derived mitochondrial oxidative capacity was found to be significantly correlated with V̇O2peak (r = -0.61; R2 = 0.37; P = 0.002), oxygen uptake at the gas exchange threshold (r = -0.49; R2 = 0.24; P = 0.02), and oxygen uptake at the respiratory compensation point (r = -0.57; R2 = 0.32; P = 0.004). CONCLUSION: NIRS provides a reliable method for deriving a measure of VL mitochondrial oxidative capacity in highly active older adults and demonstrates a significant relationship with measures of whole-body aerobic fitness.

The Acute Physiological and Perceptual Effects of Individualizing the Recovery Interval Duration Based Upon the Resolution of Muscle Oxygen Consumption During Cycling Exercise.

PURPOSE: There has been paucity in research investigating the individualization of recovery interval duration during cycling-based high-intensity interval training (HIIT). The main aim of the study was to investigate whether individualizing the duration of the recovery interval based upon the resolution of muscle oxygen consumption would improve the performance during work intervals and the acute physiological response of the HIIT session, when compared with a standardized (2:1 work recovery ratio) approach. METHODS: A total of 16 well-trained cyclists (maximal oxygen consumption: 60 [7] mL·kg-1·min-1) completed 6 laboratory visits: (Visit 1) incremental exercise test, (Visit 2) determination of the individualized (IND) recovery duration, using the individuals' muscle oxygen consumption recovery duration to baseline from a 4- and 8-minute work interval, (Visits 3-6) participants completed a 6 × 4- and a 3 × 8-minute HIIT session twice, using the IND and standardized recovery intervals. RESULTS: Recovery duration had no effect on the percentage of the work intervals spent at >90% and >95% of maximal oxygen consumption, maximal minute power output, and maximal heart rate, during the 6 × 4- and 3 × 8-minute HIIT sessions. Recovery duration had no effect on mean work interval power output, heart rate, oxygen consumption, blood lactate, and rating of perceived exertion. There were no differences in reported session RPE between recovery durations for the 6 × 4- and 3 × 8-minute HIIT sessions. CONCLUSION: Individualizing HIIT recovery duration based upon the resolution of muscle oxygen consumption to baseline levels does not improve the performance of the work intervals or the acute physiological response of the HIIT session, when compared with standardized recovery duration.

The acute physiological and perceptual effects of recovery interval intensity during cycling-based high-intensity interval training.

PURPOSE: The current study sought to investigate the role of recovery intensity on the physiological and perceptual responses during cycling-based aerobic high-intensity interval training. METHODS: Fourteen well-trained cyclists ([Formula: see text]: 62 ± 9 mL kg-1 min-1) completed seven laboratory visits. At visit 1, the participants' peak oxygen consumption ([Formula: see text]) and lactate thresholds were determined. At visits 2-7, participants completed either a 6 × 4 min or 3 × 8 min high-intensity interval training (HIIT) protocol with one of three recovery intensity prescriptions: passive (PA) recovery, active recovery at 80% of lactate threshold (80A) or active recovery at 110% of lactate threshold (110A). RESULTS: The time spent at > 80%, > 90% and > 95% of maximal minute power during the work intervals was significantly increased with PA recovery, when compared to both 80A and 110A, during both HIIT protocols (all P ≤ 0.001). However, recovery intensity had no effect on the time spent at > 90% [Formula: see text] (P = 0.11) or > 95% [Formula: see text] (P = 0.50) during the work intervals of both HIIT protocols. Session RPE was significantly higher following the 110A recovery, when compared to the PA and 80A recovery during both HIIT protocols (P < 0.001). CONCLUSION: Passive recovery facilitates a higher work interval PO and similar internal stress for a lower sRPE when compared to active recovery and therefore may be the efficacious recovery intensity prescription.